A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from New Scientist
Explore the latest news, articles and features
Mind
What to read this week: The 21st Century Brain by Hannah Critchlow
Culture
ÎçÒ¹¸£Àû1000¼¯ºÏ
Long covid reveals the harm of one-size-fits-all medical treatment
Leader
Space
Ann Leckie continues to shine with new sci-fi novel Radiant Star
Culture
Comment
Is an AI version of Mark Zuckerberg – or any boss – a good plan?
Regulars
Popular articles
Trending New Scientist articles
1
100-year-old assumption about the universe may soon be overturned
2
Weird 'transdimensional' state of matter is neither 2D nor 3D
3
Is consciousness more fundamental to reality than quantum physics?
4
We may finally have a cure for many different autoimmune conditions
5
Thought-provoking photographs capture what it feels like to have ADHD
6
Why dinosaurs lived much more complex lives than we thought
7
Humanoid robots may be about to break the 100-metre sprint record
8
The bombshell results that demand a new theory of the universe
9
How I pay almost nothing to power my house and electric car
10
Why birds are the only surviving dinosaurs
